Skip to content

A study to see the efficacy of the lotion (Development code:K8284410) on facial skin condition with Japanese women

A study to see the efficacy of the lotion (Development code:K8284410) on facial skin condition with Japanese women - A study to see the efficacy of the lotion (Development code:K8284410) on facial skin condition with Japanese women

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000020492
Enrollment
20
Registered
2016-01-07
Start date
2016-01-05
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Application of the sample lotion and the placebo lotion on one of the half-faces and another, respectively, twice a day for 8 weeks.

Sponsors

Kao Corporation
Lead Sponsor
701 Research, Inc.
Collaborator

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Healthy Japanese females with more than one pair of similar spots on both half-faces

Exclusion criteria

Exclusion criteria: Subjects with severe systemic diseases and/or skin diseases Subjects who are pregnant and/or who had a childbirth within 2 years Subjects who are receiving hormone therapies Subjects who have laser treatments for facial pigmentation (spot, bruise, etc.), acne etc. Subjects with severe sunburn or subjects who might possibly severe sunburn during the test period Subjects with sensitive skins Subjects seemed to be inappropriate to participate in this study according to the decision by investigators and/or doctors

Design outcomes

Primary

MeasureTime frame
Evaluation of dermatological assessment, measurement of skin color and that of skin shape before and after the repeated treatments of the lotions for 4 and 8 weeks.

Countries

Japan

Contacts

Public ContactMegumi Tobiishi

Kao Corporation R&D -Core Technology- Biological Science Research

tobiishi.megumi@kao.co.jp0465-34-6116

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026